Unfortunately, you’re not able to donate blood today. Not until you’re cancer-free for at least a year. Just on the outside ...

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...

Researchers have identified cancer-specific RNAs and employed machine learning models to use them as a blood-based biomarker ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine, today announced the launch ...

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support future clinical programsGelrinC is set to transform cartilage repair market with ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.